Combining cooling and thrombectomy for acute stroke treatment
Official title: Combination of Targeted Temperature Management and Thrombectomy After Acute Ischemic Stroke (COTTIS-2) - a Randomised Controlled Study
Run by University of Freiburg · NCT06301412 · Data updated 2026-11-12
This study tests if cooling the body after a stroke helps people recover better when combined with a procedure to open blocked blood vessels.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | University of Freiburg Academic / other |
| Locations | 1 site (Freiburg im Breisgau) |
| Status | Recruiting |
| Started | July 7, 2024 |
| Main results expected | March 18, 2026 |
| Study ends | June 18, 2026 |
| Registry record updated | January 6, 2025 |
| Trial ID | NCT06301412 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with acute ischemic stroke and significant neurological deficits who meet specific imaging and timing criteria.
✕Probably not a fit
Patients with intranasal obstructions or severe hemorrhagic conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of combining hypothermia with endovascular treatment in patients suffering from acute ischemic stroke due to large vessel occlusion. Participants will undergo a noninvasive cooling technique to lower their body temperature to 35°C for six hours following the reopening of the blocked vessel. The study aims to determine if this additional cooling improves clinical outcomes compared to standard treatment alone. Researchers will compare results from two groups: one receiving both hypothermia and endovascular treatment, and the other receiving only endovascular treatment.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for patients with acute ischemic stroke.
How similar studies have gone: Previous studies have shown mixed results with hypothermia in stroke treatment, making this approach both innovative and necessary to explore further.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Pre-stroke modified Rankin Scale (mRS) 0-2 \[7-point scale rating from 0 (no symptoms) to 6 (dead)\]
* Acute ischemic stroke with NIHSS \>5
* Intracranial occlusion of the M1 or M2 segment of the middle cerebral artery (MCA) or internal carotid artery (ICA) or tandem occlusion on CT-angiography or MR-angiography with indication for endovascular treatment:
* Time window 0-24h:
1. Last seen normal to groin puncture \< 6h: native CT or MRI-DWI with ASPECTS \>5
2. Last seen normal to groin puncture 6-24h or unknown time window: significant mismatch imaging according to the eligibility criteria of the DEFUSE-3 trial
* Infarct core \<70ml (DWI oder CBF\<30%)
* Penumbra \> 15ml (Tmax \>6sec)
* Ratio penumbra/core \>1.8
* with or without iv thrombolysis with rtPA
Exclusion Criteria:
* Patients with an intranasal obstruction that prevents complete insertion of the nasal cannula should not be treated with the RhinoChill system.
* Known severe hemorrhagic diathesis (International Normalized Ratio (INR) \>3.0, partial thromboplastin time (PTT) \> 70s, platelet count \< 50.000/μl)
* Brain trauma or neurovascular surgery/intervention \<3 months
* Severe infection
* Pregnant women or women of childbearing potential (women of childbearing potential with negative pregnancy test may be included)
* Known cerebral vasculitis
* Proof of bleeding in cerebral CT or MRI (cerebral microbleeds in MRI \[hypertensive or in the context of cerebral amyloid angiopathy\] is permitted).
* Known life expectancy \< 6 months
Where it's running
-
University of Freiburg, Department of Neurology
Freiburg im Breisgau, Germany Recruiting
Study contacts
- Principal investigator: Juergen Bardutzky, Prof. — University of Freiburg, Department of Neurology, Germany
- Study coordinator: Juergen Bardutzky, Prof.
- Email: juergen.bardutzky@uniklinik-freiburg.de
- Phone: +49-15237729739
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Head-of-bed position after clot-removal stroke therapy
This study tests whether keeping the head of the bed flat (0 degrees) after thrombectomy improves recovery compared with a raised position in adults who had an ischemic stroke due to large vessel blockage.
-
Tenecteplase delivered into the artery for acute medium-vessel stroke
This trial will test whether giving tenecteplase directly into the blocked artery helps adults with acute medium-vessel ischemic stroke recover better when treated within 24 hours.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal
This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.